BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khan SA, Reddy D, Gupta S. Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment? World J Biol Chem 2015; 6(4): 333-345 [PMID: 26629316 DOI: 10.4331/wjbc.v6.i4.333]
URL: https://www.wjgnet.com/1949-8454/full/v6/i4/333.htm
Number Citing Articles
1
Xiaoping Zhang, Yong Zhong, Lin Liu, Chengyou Jia, Haidong Cai, Jianshe Yang, Bo Wu, Zhongwei Lv. Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinomaCell Death & Disease 2023; 14(12) doi: 10.1038/s41419-023-06348-0
2
Hiwot Tezera Endale, Yitbarek Fantahun Mariye, Habtu Kifle Negash, Fethiya Seid Hassen, Wastina Bitewlign Asrat, Tiget Ayelgn Mengstie, Winta Tesfaye. MiRNA in cervical cancer: Diagnosis to therapy: Systematic reviewHeliyon 2024; 10(3): e24398 doi: 10.1016/j.heliyon.2024.e24398
3
Khayelihle B. Makhathini, Oualid Abboussi, Dan J. Stein, Musa V. Mabandla, William M.U. Daniels. Repetitive stress leads to impaired cognitive function that is associated with DNA hypomethylation, reduced BDNF and a dysregulated HPA axisInternational Journal of Developmental Neuroscience 2017; 60(1): 63 doi: 10.1016/j.ijdevneu.2017.04.004
4
Shanshan TIAN, Ranran LIU, Xiaolong QIAN, Xiaojing GUO, Kai ZHANG. Extraction and isolation of histones from paraffin-embedded tissues and quantitative analysis of post-translational modificationsChinese Journal of Chromatography 2021; 39(10): 1094 doi: 10.3724/SP.J.1123.2021.06018
5
Daniel Desaulniers, Cathy Cummings-Lorbetskie, Nanqin Li, Gong-Hua Xiao, Leonora Marro, Nasrin Khan, Karen Leingartner. Sodium bisulfite pyrosequencing revealed that developmental exposure to environmental contaminant mixtures does not affect DNA methylation of DNA repeats in Sprague-Dawley ratsJournal of Toxicology and Environmental Health, Part A 2017; 80(1): 32 doi: 10.1080/15287394.2016.1231644
6
Roberta Noberini, Rémi Longuespée, Cristina Richichi, Giancarlo Pruneri, Mark Kriegsmann, Giuliana Pelicci, Tiziana Bonaldi. PAT-H-MS coupled with laser microdissection to study histone post-translational modifications in selected cell populations from pathology samplesClinical Epigenetics 2017; 9(1) doi: 10.1186/s13148-017-0369-8
7
Sanket G. Shah, Tushar Mandloi, Pooja Kunte, Abhiram Natu, Mudasir Rashid, Divya Reddy, Nikhil Gadewal, Sanjay Gupta. HISTome2: a database of histone proteins, modifiers for multiple organisms and epidrugsEpigenetics & Chromatin 2020; 13(1) doi: 10.1186/s13072-020-00354-8
8
Elena G. Pasyukova, Alexander V. Symonenko, Olga Y. Rybina, Alexander M. Vaiserman. Epigenetic enzymes: A role in aging and prospects for pharmacological targetingAgeing Research Reviews 2021; 67: 101312 doi: 10.1016/j.arr.2021.101312
9
Joanna Szczepanek, Andrzej Tretyn. MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic ImplicationsBiomolecules 2023; 13(11): 1590 doi: 10.3390/biom13111590
10
Peter Kubatka, Martin Kello, Karol Kajo, Marek Samec, Karin Jasek, Desanka Vybohova, Sona Uramova, Alena Liskova, Vladimira Sadlonova, Lenka Koklesova, Radovan Murin, Marian Adamkov, Karel Smejkal, Emil Svajdlenka, Peter Solar, Samson Mathews Samuel, Monika Kassayova, Taeg Kyu Kwon, Pavol Zubor, Martin Pec, Jan Danko, Dietrich Büsselberg, Jan Mojzis. Chemopreventive and Therapeutic Efficacy of Cinnamomum zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro AnalysesMolecules 2020; 25(6): 1399 doi: 10.3390/molecules25061399
11
L Xie, J Hou, H Qi, Y Dai, W She. Histone acetylation in refractory sudden sensorineural hearing loss patients after intratympanic methylprednisolone perfusionThe Journal of Laryngology & Otology 2019; 133(10): 895 doi: 10.1017/S0022215119001865
12
Meng Ye, Tao Huang, Ying Ying, Jinyun Li, Ping Yang, Chao Ni, Chongchang Zhou, Si Chen. Detection of14-3-3 sigma(σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosisOncotarget 2017; 8(6): 9230 doi: 10.18632/oncotarget.13992
13
Daoyin Dong, E. Albert Reece, Peixin Yang. Handbook of Nutrition, Diet, and Epigenetics2019; : 1347 doi: 10.1007/978-3-319-55530-0_101
14
Yanqi Sang, Yu Deng. Current insights into the epigenetic mechanisms of skin cancerDermatologic Therapy 2019; : e12964 doi: 10.1111/dth.12964
15
Raghavendra Vadla, Devyani Haldar. Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylationCell Cycle 2018; 17(1): 110 doi: 10.1080/15384101.2017.1404207
16
Hongjuan Chai, Chunpeng Pan, Mingyang Zhang, Haizhong Huo, Haiyan Shan, Jugang Wu. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer developmentBMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10573-3
17
Lyudmila F. Gulyaeva, Nicolay E. Kushlinskiy. Regulatory mechanisms of microRNA expressionJournal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-0893-x
18
Shumin Ni, Meng Ye, Tao Huang. Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosisOncotarget 2017; 8(37): 61253 doi: 10.18632/oncotarget.18056
19
Prognostic Epigenetics2019; : 351 doi: 10.1016/B978-0-12-814259-2.00014-5
20
Azadeh Shahidian, Majid Ghassemi, Javad Mohammadi, Mohadeseh Hashemi. Bio-Engineering Approaches to Cancer Diagnosis and Treatment2020; : 45 doi: 10.1016/B978-0-12-817809-6.00003-0
21
Archismaan Ghosh, Ansuman Lahiri, Sutapa Mukherjee, Madhumita Roy, Amitava Datta. Prevention of inorganic arsenic induced squamous cell carcinoma of the skin in Swiss albino mice by black tea through epigenetic modulationHeliyon 2022; 8(8): e10341 doi: 10.1016/j.heliyon.2022.e10341
22
Madhumitha Kedhari Sundaram, Shefina Silas, Arif Hussain. Epigenetics and Reproductive Health2021; : 343 doi: 10.1016/B978-0-12-819753-0.00017-9
23
Md. Fazlul Karim, Yearul Kabir. Handbook of Cancer and Immunology2023; : 1 doi: 10.1007/978-3-030-80962-1_50-1
24
Zhicheng Zhang, Jing‐Jing Hu, Shijun Lin, Jiajun Wu, Fan Xia, Xiaoding Lou. Field effect transistor biosensors for healthcare monitoringInterdisciplinary Medicine 2024; 2(4) doi: 10.1002/INMD.20240032
25
Madhumati Bora, Pratibha Parihar. Anticancer Plants: Mechanisms and Molecular Interactions2018; : 1 doi: 10.1007/978-981-10-8417-1_1
26
Lula Smith, Samuel Anti, Natalie White, Sabita N. Saldanha. Epigenetic Mechanisms in Cancer2018; : 87 doi: 10.1016/B978-0-12-809552-2.00004-8
27
Chunxia Zhu, Xuefeng Feng, Guoliang Ye, Tao Huang. Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guidelineMedicine 2017; 96(16): e6650 doi: 10.1097/MD.0000000000006650
28
Jinhee Lee. Encyclopedia of Sensors and Biosensors2023; : 339 doi: 10.1016/B978-0-12-822548-6.00109-6
29
Ali Alavian‐Ghavanini, Joëlle Rüegg. Understanding Epigenetic Effects of Endocrine Disrupting Chemicals: From Mechanisms to Novel Test MethodsBasic & Clinical Pharmacology & Toxicology 2018; 122(1): 38 doi: 10.1111/bcpt.12878
30
Antja-Voy Hartley, Matthew Martin, Jiamin Jin, Tao Lu. Pharmacoepigenetics2019; : 885 doi: 10.1016/B978-0-12-813939-4.00037-1
31
Shahin Ramazi, Abdollah Allahverdi, Javad Zahiri. Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disordersJournal of Biosciences 2020; 45(1) doi: 10.1007/s12038-020-00099-2
32
Angela Mena Perri, Valter Agosti, Erika Olivo, Antonio Concolino, MariaTeresa De Angelis, Laura Tammè, Claudia Vincenza Fiumara, Giovanni Cuda, Domenica Scumaci. Histone proteomics reveals novel post-translational modifications in breast cancerAging 2019; 11(23): 11722 doi: 10.18632/aging.102577
33
Jugang Wu, Hongjuan Chai, Feng Li, Qing Ren, Yan Gu. SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinomaLife Sciences 2020; 260: 118406 doi: 10.1016/j.lfs.2020.118406
34
Bashir Lawal, Sung-Hui Tseng, Janet Olugbodi, Sitthichai Iamsaard, Omotayo Ilesanmi, Mohamed Mahmoud, Sahar Ahmed, Gaber Batiha, Alexander Wu. Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy ResistanceCancers 2021; 13(16): 4124 doi: 10.3390/cancers13164124
35
Yong Ding, Qihua Yang, Bojun Wang, Guoliang Ye, Xiaoqiong Tong, Aamir Ahmad. The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-AnalysisPLOS ONE 2016; 11(11): e0165509 doi: 10.1371/journal.pone.0165509
36
Yu Zheng, Xia Li, Yiming Jiang, Yufen Xu, Binbin Song, Qiang Zhou, Xiaodong Liang, Xinmei Yang. Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancerMedicine 2016; 95(49): e5433 doi: 10.1097/MD.0000000000005433
37
Tiziana Bonaldi, Roberta Noberini. Recent advances in mass spectrometry analysis of histone post-translational modifications: potential clinical impact of the PAT-H-MS approachExpert Review of Proteomics 2016; 13(3): 245 doi: 10.1586/14789450.2016.1147960
38
Qinfei Zhao, Weiquan Hu, Jing Xu, Shaoying Zeng, Xuxiang Xi, Jing Chen, Xiangsheng Wu, Suping Hu, Tianyu Zhong. Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and ImmunotherapyFrontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.919274
39
Hong Wang, Manhua Cui, Shuangli Zhang, Jie He, Li Song, Ying Chen. Relationship between RAS Association Domain Family Protein 1A Promoter Methylation and the Clinicopathological Characteristics in Patients with Ovarian Cancer: A Systematic Meta-AnalysisGynecologic and Obstetric Investigation 2018; 83(4): 349 doi: 10.1159/000484245
40
Qiang Wang, Bing Wang, Yun-mei Zhang, Wei Wang. The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysisJournal of Ovarian Research 2016; 9(1) doi: 10.1186/s13048-016-0231-1
41
Tapan Sharma. Understanding Cancer2022; : 205 doi: 10.1016/B978-0-323-99883-3.00014-7
42
Tayaba Ismail, Hyun-Kyung Lee, Chowon Kim, Taejoon Kwon, Tae Joo Park, Hyun-Shik Lee. KDM1A microenvironment, its oncogenic potential, and therapeutic significanceEpigenetics & Chromatin 2018; 11(1) doi: 10.1186/s13072-018-0203-3
43
Roshani Sinha, Mai Dvorak, Ananthakrishnan Ganesan, Larry Kalesinskas, Charlotte M. Niemeyer, Christian Flotho, Kathleen M. Sakamoto, Norman Lacayo, Rachana Vinay Patil, Rhonda Perriman, Alma-Martina Cepika, Yunying Lucy Liu, Alex Kuo, Paul J. Utz, Purvesh Khatri, Alice Bertaina. Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone LandscapeCancers 2023; 15(21): 5204 doi: 10.3390/cancers15215204
44
Franziska Singer, Anja Irmisch, Nora C. Toussaint, Linda Grob, Jochen Singer, Thomas Thurnherr, Niko Beerenwinkel, Mitchell P. Levesque, Reinhard Dummer, Luca Quagliata, Sacha I. Rothschild, Andreas Wicki, Christian Beisel, Daniel J. Stekhoven. SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinicsBMC Medical Informatics and Decision Making 2018; 18(1) doi: 10.1186/s12911-018-0680-0
45
Richard A. Stein, Abhi N. Deverakonda. Cancer Research: An Interdisciplinary ApproachInterdisciplinary Cancer Research 2022; 1: 183 doi: 10.1007/16833_2022_86
46
Yunhao Yang, Nanzhi Luo, Zhipeng Gong, Wenjing Zhou, Yin Ku, Yaohui Chen. Lactate and lysine lactylation of histone regulate transcription in cancerHeliyon 2024; 10(21): e38426 doi: 10.1016/j.heliyon.2024.e38426
47
Sreepoorna Pramodh, Ritu Raina, Arif Hussain, Sali Abubaker Bagabir, Shafiul Haque, Syed Tasleem Raza, Mohammad Rehan Ajmal, Shalini Behl, Deepika Bhagavatula. Luteolin Causes 5′CpG Demethylation of the Promoters of TSGs and Modulates the Aberrant Histone Modifications, Restoring the Expression of TSGs in Human Cancer CellsInternational Journal of Molecular Sciences 2022; 23(7): 4067 doi: 10.3390/ijms23074067
48
Marek Samec, Alena Liskova, Lenka Koklesova, Veronika Mestanova, Maria Franekova, Monika Kassayova, Bianka Bojkova, Sona Uramova, Pavol Zubor, Katarina Janikova, Jan Danko, Samson Samuel, Dietrich Büsselberg, Peter Kubatka. Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin EquilibriumBiomolecules 2019; 9(12): 829 doi: 10.3390/biom9120829
49
Tapan Sharma. Understanding Cancer2022; : 149 doi: 10.1016/B978-0-323-99883-3.00019-6
50
Mariano Colón-Caraballo, Idhaliz Flores-Caldera. Epigenetics in Human Disease2024; : 883 doi: 10.1016/B978-0-443-21863-7.00008-1
51
Divya Reddy, Bharat Khade, Riddhi Pandya, Sanjay Gupta. A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumoursClinical Epigenetics 2017; 9(1) doi: 10.1186/s13148-017-0330-x
52
Daoyin Dong, E. Albert Reece, Peixin Yang. Handbook of Nutrition, Diet, and Epigenetics2017; : 1 doi: 10.1007/978-3-319-31143-2_101-1
53
Sanga Mitra, Sayak Ganguli, Jayprokas Chakrabarti. Cancer and Noncoding RNAs2018; : 1 doi: 10.1016/B978-0-12-811022-5.00001-2
54
Trillitye Paullin, Chase Powell, Christopher Menzie, Robert Hill, Feng Cheng, Christopher J. Martyniuk, Sandy D. Westerheide, Surinder K. Batra. Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responsesPLOS ONE 2017; 12(8): e0182930 doi: 10.1371/journal.pone.0182930
55
Qingfeng Guo, Yuming Hua. The assessment of circulating cell-free DNA as a diagnostic tool for breast cancer: an updated systematic review and meta-analysis of quantitative and qualitative ssaysClinical Chemistry and Laboratory Medicine (CCLM) 2021; 59(9): 1479 doi: 10.1515/cclm-2021-0193
56
Guanyuan Liu. CDH1 Promoter Methylation in Patients with Cervical Carcinoma: A Systematic Meta-Analysis with Trial Sequential Analysis Future Oncology 2018; 14(1): 51 doi: 10.2217/fon-2017-0267
57
Fatima Domenica Elisa De Palma, Vincent Carbonnier, Francesco Salvatore, Guido Kroemer, Jonathan G. Pol, Maria Chiara Maiuri. Systematic Investigation of the Diagnostic and Prognostic Impact of LINC01087 in Human CancersCancers 2022; 14(23): 5980 doi: 10.3390/cancers14235980
58
Elena G. Pasyukova, Alexander V. Symonenko, Olga Y. Rybina. Reference Module in Biomedical Sciences2019;  doi: 10.1016/B978-0-12-801238-3.11298-X
59
Jiann-Jyh Lai, Freidrich M. Cruz, Kenneth L. Rock. Immune Sensing of Cell Death through Recognition of Histone Sequences by C-Type Lectin-Receptor-2d Causes Inflammation and Tissue InjuryImmunity 2020; 52(1): 123 doi: 10.1016/j.immuni.2019.11.013
60
Alireza Nemati, Mohamad Sadegh Aghajanzadeh, Mahdi Rooberahan. An Overview on Cancer Diagnosis based on Antibody-Based Immune TechniquesModern Medical Laboratory Journal 2020; 3(2): 100 doi: 10.30699/mmlj17.3.1.100
61
Yuting Zhang, Huiting Huang, Libo Jin, Sue Lin. Anticarcinogenic Effects of Isothiocyanates on Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2022; 23(22): 13834 doi: 10.3390/ijms232213834
62
Kamila Romanowska, Agnieszka Sobecka, Agnieszka A. Rawłuszko-Wieczorek, Wiktoria M. Suchorska, Wojciech Golusiński. Head and Neck Squamous Cell Carcinoma: Epigenetic LandscapeDiagnostics 2020; 11(1): 34 doi: 10.3390/diagnostics11010034
63
Prakriti Sen, Pooja Ganguly, Niladri Ganguly. Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer (Review)Oncology Letters 2017;  doi: 10.3892/ol.2017.7292
64
Mariano Colón-Caraballo, Idhaliz Flores-Caldera. Epigenetics in Human Disease2018; : 717 doi: 10.1016/B978-0-12-812215-0.00023-6
65
Zipei Cao, Lijuan Wei, Weizhi Zhu, Xuping Yao. Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA)Medicine 2018; 97(12): e0182 doi: 10.1097/MD.0000000000010182
66
Giulia Robusti, Alessandro Vai, Tiziana Bonaldi, Roberta Noberini. Investigating pathological epigenetic aberrations by epi-proteomicsClinical Epigenetics 2022; 14(1) doi: 10.1186/s13148-022-01371-y
67
Hitoshi Aihara, Takeya Nakagawa, Hirofumi Mizusaki, Mitsuhiro Yoneda, Masanori Kato, Masamichi Doiguchi, Yuko Imamura, Miki Higashi, Tsuyoshi Ikura, Tomonori Hayashi, Yoshiaki Kodama, Masaya Oki, Toshiyuki Nakayama, Edwin Cheung, Hiroyuki Aburatani, Ken-ichi Takayama, Haruhiko Koseki, Satoshi Inoue, Yukio Takeshima, Takashi Ito. Histone H2A T120 Phosphorylation Promotes Oncogenic Transformation via Upregulation of Cyclin D1Molecular Cell 2016; 64(1): 176 doi: 10.1016/j.molcel.2016.09.012
68
Tapan Sharma. Understanding Cancer2022; : 133 doi: 10.1016/B978-0-323-99883-3.00012-3
69
Cheng Chen, Ying Zhu, Haibo Zhang, Lan Xiao. Prognostic Effects of RASSF1A, BRCA1, APC, and p16 Promoter Methylation in Ovarian Cancer: A Meta-AnalysisGynecologic and Obstetric Investigation 2024; 89(5): 363 doi: 10.1159/000538673
70
Liang Xia, Wenzhu Zhang, Li Gao. Clinical and prognostic effects ofCDKN2A,CDKN2BandCDH13promoter methylation in ovarian cancer: a study using meta-analysis and TCGA dataBiomarkers 2019; 24(7): 700 doi: 10.1080/1354750X.2019.1652685
71
Yingxue Zhang, Eid Alshammari, Jacob Sobota, Zhe Yang. Genomic and Epigenomic Biomarkers of Toxicology and Disease2022; : 273 doi: 10.1002/9781119807704.ch13
72
Priscilla Van den Ackerveken, Alison Lobbens, Jean-Valery Turatsinze, Victor Solis-Mezarino, Moritz Völker-Albert, Axel Imhof, Marielle Herzog. A novel proteomics approach to epigenetic profiling of circulating nucleosomesScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86630-3
73
Ashok Kumar, Preeti Maurya, Jeffrey J. Hayes. Post-Translation Modifications and Mutations of Human Linker Histone Subtypes: Their Manifestation in DiseaseInternational Journal of Molecular Sciences 2023; 24(2): 1463 doi: 10.3390/ijms24021463
74
Bin Xie, Feng Peng, Fengping He, Yixing Cheng, Jiangtao Cheng, Zhibing Zhou, Wei Mao. DNA methylation influences the CTCF‐modulated transcription of RASSF1A in lung cancer cellsCell Biology International 2022; 46(11): 1900 doi: 10.1002/cbin.11868
75
Xianneng Sheng, Yu Guo, Yang Lu. Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancerMedicine 2017; 96(28): e7476 doi: 10.1097/MD.0000000000007476
76
Alessandro Vai, Roberta Noberini, Chiara Ghirardi, Dieggo Rodrigues de Paula, Michele Carminati, Rani Pallavi, Nathália Araújo, Patrick Varga-Weisz, Tiziana Bonaldi. Improved Mass Spectrometry–Based Methods Reveal Abundant Propionylation and Tissue-Specific Histone Propionylation ProfilesMolecular & Cellular Proteomics 2024; 23(7): 100799 doi: 10.1016/j.mcpro.2024.100799
77
Huayue Cong, Xiaoqiang Guo, Bo Fan, Yingzi Liu, Changzheng Dong, Aixia Sui. Dimethylation of histone H3 lysine 36 (H3K36me2) as a potential biomarker for glioma diagnosis, grading, and prognosisJournal of Neuropathology & Experimental Neurology 2023; 82(5): 412 doi: 10.1093/jnen/nlad016
78
Anubhav Srivastava, Darren John Creek. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and ProteomicsPROTEOMICS 2019; 19(10) doi: 10.1002/pmic.201700448
79
Shahid Banday, Zeenat Farooq, Shabir Ahmad Ganai, Mohammad Altaf. Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemiasClinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00860-2
80
Katerina V. Gurova. Chromatin Stability as a Target for Cancer TreatmentBioEssays 2019; 41(1) doi: 10.1002/bies.201800141
81
Marilena Celano, Catia Mio, Marialuisa Sponziello, Antonella Verrienti, Stefania Bulotta, Cosimo Durante, Giuseppe Damante, Diego Russo. Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancerMolecular and Cellular Endocrinology 2018; 469: 38 doi: 10.1016/j.mce.2017.05.036
82
Irfan-ur-Rauf Tak, Fasil Ali, Jehangir Shafi Dar, Aqib Rehman Magray, Bashir A. Ganai, M.Z. Chishti. Protein Modificomics2019; : 1 doi: 10.1016/B978-0-12-811913-6.00001-1
83
Erika Langsfeld, Laimonis A. Laimins. Human Papillomaviruses: Research Priorities for the Next DecadeTrends in Cancer 2016; 2(5): 234 doi: 10.1016/j.trecan.2016.04.001
84
Jugang Wu, Hongjuan Chai, Xin Xu, Jiwei Yu, Yan Gu. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancerMolecular Oncology 2020; 14(6): 1397 doi: 10.1002/1878-0261.12689
85
Vladimir Y. Ovchinnikov, Denis V. Antonets, Lyudmila F. Gulyaeva. The search of CAR, AhR, ESRs binding sites in promoters of intronic and intergenic microRNAsJournal of Bioinformatics and Computational Biology 2018; 16(01): 1750029 doi: 10.1142/S0219720017500299
86
Zhenghui Liu, Yingxue Gao, Xiong Li. Cancer epigenetics and the potential of epigenetic drugs for treating solid tumorsExpert Review of Anticancer Therapy 2019; 19(2): 139 doi: 10.1080/14737140.2019.1552139
87
Roberta Noberini, Giulia Robusti, Tiziana Bonaldi. Mass spectrometry‐based characterization of histones in clinical samples: applications, progress, and challengesThe FEBS Journal 2022; 289(5): 1191 doi: 10.1111/febs.15707
88
Chunyan Shen, Qifang Sheng, Xiaojie Zhang, Yuling Fu, Kemiao Zhu. Hypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancerJournal of Ovarian Research 2016; 9(1) doi: 10.1186/s13048-016-0271-6
89
Dorota Komar, Przemyslaw Juszczynski. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapyClinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00941-2
90
Jugang Wu, Hongjuan Chai, Haiyan Shan, Chunpeng Pan, Xin Xu, Wenpei Dong, Jiwei Yu, Yan Gu. Histone Methyltransferase SETD1A Induces Epithelial-Mesenchymal Transition to Promote Invasion and Metastasis Through Epigenetic Reprogramming of Snail in Gastric CancerFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.657888
91
Pritha Bhattacharjee, Somnath Paul, Sandip Bhattacharjee, Ashok K. Giri, Pritha Bhattacharjee. Association of H3K79 monomethylation (an epigenetic signature) with arsenic-induced skin lesionsMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2018; 807: 1 doi: 10.1016/j.mrfmmm.2017.11.001